Is Lactobacillus Helveticus Stress Randomized Trial safe?

Updated October 2026

Quick Answer

Lactobacillus Helveticus Stress Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Among the measured SCFAs, only the butyric acid concentration in PG increased significantly during supplementation (baseline vs.

Key Takeaways

  • 01Among the measured SCFAs, only the butyric acid concentration in PG increased significantly during supplementation (baseline vs. [Drzymała S (2026)]
  • 02Background : Recovering from COVID-19 does not always lead to complete recovery, and many patients report symptoms of anxiety and depression. [Drzymała S (2026)]
  • 03The aim of this study was to evaluate the impact of psychobiotic therapy on the effectiveness of treating anxiety and depressive symptoms in individuals who had previously experienced COVID-19. [Drzymała S (2026)]
The current Migaku evidence database contains 1 reusable source document for Lactobacillus Helveticus Stress Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Among the measured SCFAs, only the butyric acid concentration in PG increased significantly during supplementation (baseline vs. [Drzymała S (2026); evidence level 2] - Background : Recovering from COVID-19 does not always lead to complete recovery, and many patients report symptoms of anxiety and depression. [Drzymała S (2026); evidence level 2] - The aim of this study was to evaluate the impact of psychobiotic therapy on the effectiveness of treating anxiety and depressive symptoms in individuals who had previously experienced COVID-19. [Drzymała S (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. The Impact of Psychobiotic Therapy on Anxiety and Depressive Symptoms in Patients with Post-COVID Syndrome-A Randomized, Double-Blind, Placebo-Controlled Trial.